SUNLANT is a medical diagnosis overall solution provider integrating R & D, production, sales and medical testing services of in vitro diagnosis rapid detection products. It is also one of the leading enterprises in chemiluminescence detection of microarray protein chips in China. Over the past decade, the company has participated in a number of national "863" projects, key high-tech projects such as the Ministry of science and technology, the Department of science and technology of Jiangsu Province, the Department of industry and information technology and the national development and Reform Commission, and developed and studied a number of products and scientific research achievements. The products are widely used in health fields such as clinical testing, critical illness, grass-roots medical treatment and epidemic prevention and control.In October of 2020, with the approval of the Ministry of human resources and social security, the establishment of Sunlant postdoctoral research workstation was agreed. The postdoctoral scientific research workstation of the company mainly carries out scientific research activities around the technological innovation in the field of medical devices and medical testing, such as microarray chemiluminescence immunoassay technology platform, electrochemiluminescence technology platform, molecular diagnosis technology platform, chemiluminescence immunoassay instrument technology platform and biological raw material technology platform. Promote enterprise product upgrading through the application of high and new technology.
